We are live on ! Find out more
TBA

Tower Bridge Advisors Portfolio holdings

AUM $1.04B
1-Year Est. Return 23.66%
This Fund
S&P 500
This Quarter Est. Return
+3.99%
1 Year Est. Return
+23.66%
3 Year Est. Return
+73.59%
5 Year Est. Return
+91.36%
10 Year Est. Return
+296.99%
AUM
$825M
AUM Growth
+$3.75M
Cap. Flow
-$17.8M
Cap. Flow %
-2.16%
Top 10 Hldgs %
23.21%
Holding
217
New
9
Increased
35
Reduced
117
Closed
7

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$3.03M
2
CAT icon
Caterpillar
CAT
+$2.21M
3
CVS icon
CVS Health
CVS
+$2.2M
4
GS icon
Goldman Sachs
GS
+$2.12M
5
CL icon
Colgate-Palmolive
CL
+$1.77M

Sector Composition

Rank Sector Weight
1 Healthcare 15.38%
2 Technology 14.28%
3 Financials 13.95%
4 Industrials 10.85%
5 Consumer Staples 9.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APD icon
51
Air Products & Chemicals
APD
$66.3B
$5.96M 0.72%
41,445
-5,708
-12% -$799K
RJF icon
52
Raymond James Financial
RJF
$32.5B
$5.85M 0.71%
126,770
-114
-0.1% -$5.04K
EPD icon
53
Enterprise Products Partners
EPD
$83.8B
$5.83M 0.71%
215,753
-9,550
-4% -$249K
DHR icon
54
Danaher
DHR
$135B
$5.68M 0.69%
82,347
-2,949
-3% -$205K
AET
55
DELISTED
Aetna Inc
AET
$5.42M 0.66%
43,707
-250
-0.6% -$29.9K
GS icon
56
Goldman Sachs
GS
$313B
$5.11M 0.62%
21,334
-10,425
-33% -$2.12M
TOL icon
57
Toll Brothers
TOL
$14B
$5.03M 0.61%
162,121
+17,475
+12% +$518K
NKE icon
58
Nike
NKE
$61.9B
$4.76M 0.58%
93,643
+1,375
+1% +$70.5K
TSM icon
59
TSMC
TSM
$2.09T
$4.59M 0.56%
159,622
-6,968
-4% -$210K
CMCSA icon
60
Comcast
CMCSA
$79.1B
$4.52M 0.55%
131,048
-648
-0.5% -$21.6K
FLR icon
61
Fluor
FLR
$7.29B
$4.48M 0.54%
85,275
+5,500
+7% +$286K
PRGO icon
62
Perrigo
PRGO
$1.4B
$4.39M 0.53%
52,728
-19,514
-27% -$1.69M
HAL icon
63
Halliburton
HAL
$27.9B
$4.37M 0.53%
80,732
-10,633
-12% -$530K
FTV icon
64
Fortive
FTV
$19B
$4.14M 0.5%
122,269
+16,543
+16% +$547K
XRAY icon
65
Dentsply Sirona
XRAY
$2.59B
$3.88M 0.47%
67,136
+744
+1% +$44K
BRK.B icon
66
Berkshire Hathaway Class B
BRK.B
$1.07T
$3.85M 0.47%
23,622
-200
-0.8% -$30.8K
CFR icon
67
Cullen/Frost Bankers
CFR
$10.3B
$3.85M 0.47%
43,595
-1,140
-3% -$91.4K
PX
68
DELISTED
Praxair Inc
PX
$3.61M 0.44%
30,845
-8,760
-22% -$1.04M
UNFI icon
69
United Natural Foods
UNFI
$3.01B
$3.45M 0.42%
72,255
-14,400
-17% -$647K
DD
70
DELISTED
Du Pont De Nemours E I
DD
$3.32M 0.4%
45,239
-1,000
-2% -$71K
GS.PRA icon
71
Goldman Sachs Group Inc Depositary Shares
GS.PRA
$570M
$3.31M 0.4%
149,975
-5,516
-4% -$122K
RL icon
72
Ralph Lauren
RL
$22.2B
$3.31M 0.4%
36,595
-5,890
-14% -$598K
CHKP icon
73
Check Point Software Technologies
CHKP
$13.3B
$3.24M 0.39%
38,370
-1,175
-3% -$96.4K
EMR icon
74
Emerson Electric
EMR
$82.9B
$3.19M 0.39%
57,214
-875
-2% -$47.1K
IVZ icon
75
Invesco
IVZ
$13.3B
$3.04M 0.37%
+100,155
New +$3.08M

Similar funds

Tower Bridge Advisors's Q4 2016 Portfolio in Review

As of Q4 2016, Tower Bridge Advisors held 217 positions worth $825M, up 0.46% from $821M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Bridge Advisors's Q4 2016 filing shows 9 new, 35 increased, 117 reduced and 7 closed positions. Its largest new stake was Invesco: 100,155 shares worth $3.04M. The largest sale was Novartis, an estimated $3.03M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Technology and Financials.

  • Tower Bridge Advisors's largest Q4 2016 buy was Invesco: 100,155 shares worth $3.04M.
  • Tower Bridge Advisors added most to Medtronic in Q4 2016, an estimated $8.4M increase.
  • Tower Bridge Advisors's biggest Q4 2016 reduction was Novartis, cutting an estimated $3.03M.
  • Tower Bridge Advisors fully exited PIEDMONT NATURAL GAS CO INC(NC in Q4 2016, selling an estimated $931K.
  • Tower Bridge Advisors's ten largest holdings make up 23% of its $825M portfolio in Q4 2016.
  • Tower Bridge Advisors opened 9 new positions and closed 7 in Q4 2016.
  • Tower Bridge Advisors's portfolio value rose 0.46% quarter-over-quarter to $825M.

Based on Tower Bridge Advisors's 13F filing for Q4 2016, filed 31 Jan 2017.